TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
DNA

Ginkgo Bioworks Holdings

Healthcare · Biotechnology

11.50$ -7.6% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow DNA
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +28.9% +109.7% +46.3% +68.2% -11.9% -6.4%
– -38.3% +337,299.2% +20.2% -88.1% -51.1% -27.4%
– -93.6% +46,800.6% +15.6% – – –
– -350.7% – – – -400.5% –
– +160.2% -2.2% -7.5% -21.9% +53.3% -87.7%
– -10.0% +9.1% -8.0% +19.7% -22.9% +286.1%
– – – -99.9% – – –
– – -127.5% +0.0% -99.9% – +23,077.4%
– -100.4% +50.1% – -101.3% -30.7% -60.5%
– -78.0% +1,598.6% -93.8% -103.4% -45.9% –
– -138.7% – -118.5% – – –
– – – – – – –

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?